VANGUARD GROUP INC - DIFFUSION PHARMACEUTICALS IN ownership

DIFFUSION PHARMACEUTICALS IN's ticker is DFFN and the CUSIP is 253748206. A total of 9 filers reported holding DIFFUSION PHARMACEUTICALS IN in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
VANGUARD GROUP INC ownership history of DIFFUSION PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2018$386,000
-8.3%
894,732
-2.8%
0.00%
Q2 2018$421,000
-14.8%
920,115
+1.7%
0.00%
Q1 2018$494,000
+81.6%
904,815
+295.7%
0.00%
Q4 2017$272,000
+27.1%
228,643
+77.1%
0.00%
Q3 2017$214,000
-13.4%
129,084
+21.6%
0.00%
Q2 2017$247,000
-8.5%
106,182
+56.8%
0.00%
Q1 2017$270,00067,7110.00%
Other shareholders
DIFFUSION PHARMACEUTICALS IN shareholders Q1 2017
NameSharesValueWeighting ↓
Swift Run Capital 2,348,017$1,014,0000.88%
Signature Financial Management, Inc. 12,350$5,0000.00%
Virtu Financial LLC 41,515$18,0000.00%
Smithfield Trust Co 2,052$1,0000.00%
VANGUARD GROUP INC 894,732$386,0000.00%
JOYN Advisors, Inc. 1,740$1,0000.00%
JANE STREET GROUP, LLC 18,787$8,0000.00%
St. Johns Investment Management Company, LLC 23$00.00%
UBS Group AG 31,096$13,0000.00%
Advisor Group, Inc. 4,370$2,0000.00%
View complete list of DIFFUSION PHARMACEUTICALS IN shareholders